Evidence map›Paper›PMID 31318308›Full record

ArticlemAbs2019

Binding symmetry and surface flexibility mediate antibody self-association.

Joseph D Schrag, Marie-Ève Picard, Francis Gaudreault, Louis-Patrick Gagnon, Jason Baardsnes, Mahder S Manenda, Joey Sheff, Christophe Deprez, Cassio Baptista, Hervé Hogues and 4 more

Open access · goldAbstract read
In one paragraph

Article in mAbs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Joseph D SchragHuman Health Therapeutics Research Centre, National Research Council Canada , Montreal , QC H4P 2R2 , Canada.
Marie-Ève PicardDépartement de Biochimie, de Microbiologie et de Bio-informatique, PROTEO, and Institut de Biologie Intégrative et des Systèmes (IBIS), Université Laval, Pavillon Charles-Eugène-Marchand , Québec City, QC G1V 0A6 , Canada.ORCID 0000-0002-4316-2830
Francis GaudreaultHuman Health Therapeutics Research Centre, National Research Council Canada , Montreal , QC H4P 2R2 , Canada.ORCID 0000-0001-5656-3118
Louis-Patrick GagnonHuman Health Therapeutics Research Centre, National Research Council Canada , Montreal , QC H4P 2R2 , Canada.ORCID 0000-0001-7417-866X
Jason BaardsnesHuman Health Therapeutics Research Centre, National Research Council Canada , Montreal , QC H4P 2R2 , Canada.ORCID 0000-0001-5587-3034
Mahder S ManendaDépartement de Biochimie, de Microbiologie et de Bio-informatique, PROTEO, and Institut de Biologie Intégrative et des Systèmes (IBIS), Université Laval, Pavillon Charles-Eugène-Marchand , Québec City, QC G1V 0A6 , Canada.ORCID 0000-0002-8640-5556
Joey SheffHuman Health Therapeutics Research Centre, National Research Council Canada , Ottawa , ON K1A 0R6 , Canada.ORCID 0000-0002-9269-6863
Christophe DeprezHuman Health Therapeutics Research Centre, National Research Council Canada , Montreal , QC H4P 2R2 , Canada.ORCID 0000-0003-2687-3144
Cassio BaptistaHuman Health Therapeutics Research Centre, National Research Council Canada , Montreal , QC H4P 2R2 , Canada.
Hervé HoguesHuman Health Therapeutics Research Centre, National Research Council Canada , Montreal , QC H4P 2R2 , Canada.
John F KellyHuman Health Therapeutics Research Centre, National Research Council Canada , Ottawa , ON K1A 0R6 , Canada.
Enrico O PurisimaHuman Health Therapeutics Research Centre, National Research Council Canada , Montreal , QC H4P 2R2 , Canada.
Rong ShiDépartement de Biochimie, de Microbiologie et de Bio-informatique, PROTEO, and Institut de Biologie Intégrative et des Systèmes (IBIS), Université Laval, Pavillon Charles-Eugène-Marchand , Québec City, QC G1V 0A6 , Canada.ORCID 0000-0001-8494-900X
Traian SuleaHuman Health Therapeutics Research Centre, National Research Council Canada , Montreal , QC H4P 2R2 , Canada.ORCID 0000-0001-5301-8261
National Research Council Canada · CAUniversité Laval · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Solution stability is an important factor in the optimization of engineered biotherapeutic candidates such as monoclonal antibodies because of its possible effects on manufacturability, pharmacology, efficacy and safety. A detailed atomic understanding of the mechanisms governing self-association of natively folded protein monomers is required to devise predictive tools to guide screening and re-engineering along the drug development pipeline. We investigated pairs of affinity-matured full-size antibodies and observed drastically different propensities to aggregate from variants differing by a single amino-acid. Biophysical testing showed that antigen-binding fragments (Fabs) from the aggregating antibodies also reversibly associated with equilibrium dissociation constants in the low-micromolar range. Crystal structures (PDB accession codes 6MXR, 6MXS, 6MY4, 6MY5) and bottom-up hydrogen-exchange mass spectrometry revealed that Fab self-association occurs in a symmetric mode that involves the antigen complementarity-determining regions. Subtle local conformational changes incurred upon point mutation of monomeric variants foster formation of complementary polar interactions and hydrophobic contacts to generate a dimeric Fab interface. Testing of popular

Indexed as

Antibodies, MonoclonalBioengineeringComplementarity Determining RegionsDimerizationHumansImmunoglobulin Fab FragmentsMass SpectrometryMutationProtein AggregatesProtein ConformationProtein FoldingProtein StabilityStereoisomerismStructure-Activity RelationshipAntibodies, MonoclonalComplementarity Determining RegionsImmunoglobulin Fab FragmentsProtein AggregatesAggregationnative foldingprediction methodsingle point mutationstructure-aggregation relationship

Identifiers

PMID31318308
PMCPMC6748613
OpenAlexW2963889829

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.